China’s Biotech Surge: Sino Biological’s 20% Rally Fuels Big‑Ticket Growth
Discover how Sino Biological’s strategic partnerships, AI‑driven R&D, and China’s new biotech policy are driving a 20% stock surge and positioning it for long‑term growth.
4 minutes to read